Logo image of MYO

MYOMO INC (MYO) Stock Fundamental Analysis

NYSEARCA:MYO - US62857J2015 - Common Stock

1.09 USD
-0.09 (-7.63%)
Last: 8/25/2025, 4:16:02 PM
1.07 USD
-0.02 (-1.83%)
After Hours: 8/25/2025, 4:16:02 PM
Fundamental Rating

3

Overall MYO gets a fundamental rating of 3 out of 10. We evaluated MYO against 185 industry peers in the Health Care Equipment & Supplies industry. MYO may be in some trouble as it scores bad on both profitability and health. MYO is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MYO had negative earnings in the past year.
MYO had a negative operating cash flow in the past year.
MYO had negative earnings in each of the past 5 years.
MYO had a negative operating cash flow in each of the past 5 years.
MYO Yearly Net Income VS EBIT VS OCF VS FCFMYO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

MYO's Return On Assets of -24.11% is in line compared to the rest of the industry. MYO outperforms 45.41% of its industry peers.
MYO's Return On Equity of -52.93% is in line compared to the rest of the industry. MYO outperforms 47.57% of its industry peers.
Industry RankSector Rank
ROA -24.11%
ROE -52.93%
ROIC N/A
ROA(3y)-58.67%
ROA(5y)-62.8%
ROE(3y)-94.75%
ROE(5y)-92.3%
ROIC(3y)N/A
ROIC(5y)N/A
MYO Yearly ROA, ROE, ROICMYO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

MYO has a better Gross Margin (69.24%) than 77.84% of its industry peers.
MYO's Gross Margin has improved in the last couple of years.
MYO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5Y2.49%
MYO Yearly Profit, Operating, Gross MarginsMYO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

3

2. Health

2.1 Basic Checks

MYO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MYO has more shares outstanding
The number of shares outstanding for MYO has been increased compared to 5 years ago.
There is no outstanding debt for MYO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MYO Yearly Shares OutstandingMYO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MYO Yearly Total Debt VS Total AssetsMYO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

MYO has an Altman-Z score of -1.99. This is a bad value and indicates that MYO is not financially healthy and even has some risk of bankruptcy.
MYO's Altman-Z score of -1.99 is on the low side compared to the rest of the industry. MYO is outperformed by 61.62% of its industry peers.
MYO has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
MYO's Debt to Equity ratio of 0.22 is in line compared to the rest of the industry. MYO outperforms 52.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z -1.99
ROIC/WACCN/A
WACC8.9%
MYO Yearly LT Debt VS Equity VS FCFMYO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

MYO has a Current Ratio of 2.39. This indicates that MYO is financially healthy and has no problem in meeting its short term obligations.
MYO has a Current ratio (2.39) which is comparable to the rest of the industry.
MYO has a Quick Ratio of 2.03. This indicates that MYO is financially healthy and has no problem in meeting its short term obligations.
MYO has a Quick ratio of 2.03. This is comparable to the rest of the industry: MYO outperforms 52.43% of its industry peers.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 2.03
MYO Yearly Current Assets VS Current LiabilitesMYO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.54% over the past year.
The Revenue has grown by 93.07% in the past year. This is a very strong growth!
Measured over the past years, MYO shows a very strong growth in Revenue. The Revenue has been growing by 53.36% on average per year.
EPS 1Y (TTM)11.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
Revenue 1Y (TTM)93.07%
Revenue growth 3Y32.93%
Revenue growth 5Y53.36%
Sales Q2Q%28.34%

3.2 Future

Based on estimates for the next years, MYO will show a very strong growth in Earnings Per Share. The EPS will grow by 32.47% on average per year.
Based on estimates for the next years, MYO will show a very strong growth in Revenue. The Revenue will grow by 23.80% on average per year.
EPS Next Y-125.76%
EPS Next 2Y-24.88%
EPS Next 3Y14.34%
EPS Next 5Y32.47%
Revenue Next Year33.73%
Revenue Next 2Y28.52%
Revenue Next 3Y25.7%
Revenue Next 5Y23.8%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MYO Yearly Revenue VS EstimatesMYO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
MYO Yearly EPS VS EstimatesMYO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100 -150

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYO. In the last year negative earnings were reported.
Also next year MYO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYO Price Earnings VS Forward Price EarningsMYO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYO Per share dataMYO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

MYO's earnings are expected to grow with 14.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.88%
EPS Next 3Y14.34%

More info and screens

0

5. Dividend

5.1 Amount

MYO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MYOMO INC

NYSEARCA:MYO (8/25/2025, 4:16:02 PM)

After market: 1.07 -0.02 (-1.83%)

1.09

-0.09 (-7.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners55.66%
Inst Owner Change2.92%
Ins Owners5.48%
Ins Owner Change12.13%
Market Cap41.20M
Analysts80
Price Target5.41 (396.33%)
Short Float %4.56%
Short Ratio1.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.48%
Min EPS beat(2)-4.22%
Max EPS beat(2)-2.75%
EPS beat(4)2
Avg EPS beat(4)18.06%
Min EPS beat(4)-4.22%
Max EPS beat(4)50.5%
EPS beat(8)4
Avg EPS beat(8)17.38%
EPS beat(12)7
Avg EPS beat(12)14.73%
EPS beat(16)10
Avg EPS beat(16)13.79%
Revenue beat(2)2
Avg Revenue beat(2)5.03%
Min Revenue beat(2)4.48%
Max Revenue beat(2)5.57%
Revenue beat(4)4
Avg Revenue beat(4)10.8%
Min Revenue beat(4)4.48%
Max Revenue beat(4)20.73%
Revenue beat(8)6
Avg Revenue beat(8)6.89%
Revenue beat(12)8
Avg Revenue beat(12)5.03%
Revenue beat(16)12
Avg Revenue beat(16)10.75%
PT rev (1m)-39.08%
PT rev (3m)-42.7%
EPS NQ rev (1m)-144.32%
EPS NQ rev (3m)-1333.33%
EPS NY rev (1m)-227.59%
EPS NY rev (3m)-227.59%
Revenue NQ rev (1m)-25.54%
Revenue NQ rev (3m)-13.64%
Revenue NY rev (1m)-19.06%
Revenue NY rev (3m)-19.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.01
P/FCF N/A
P/OCF N/A
P/B 2.34
P/tB 2.34
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS1.08
BVpS0.47
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.11%
ROE -52.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.24%
FCFM N/A
ROA(3y)-58.67%
ROA(5y)-62.8%
ROE(3y)-94.75%
ROE(5y)-92.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5Y2.49%
F-Score3
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 212.49%
Cap/Sales 7.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.39
Quick Ratio 2.03
Altman-Z -1.99
F-Score3
WACC8.9%
ROIC/WACCN/A
Cap/Depr(3y)74.6%
Cap/Depr(5y)98.18%
Cap/Sales(3y)1.88%
Cap/Sales(5y)1.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
EPS Next Y-125.76%
EPS Next 2Y-24.88%
EPS Next 3Y14.34%
EPS Next 5Y32.47%
Revenue 1Y (TTM)93.07%
Revenue growth 3Y32.93%
Revenue growth 5Y53.36%
Sales Q2Q%28.34%
Revenue Next Year33.73%
Revenue Next 2Y28.52%
Revenue Next 3Y25.7%
Revenue Next 5Y23.8%
EBIT growth 1Y1.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year10.38%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-71.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.3%
OCF growth 3YN/A
OCF growth 5YN/A